Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 nalmefene (Selincro) trial in nervous system disease
2016-002805-21Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nalmefene in neurological diseases, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Oct 2016; status: completed.
02
Drugs
nalmefene
03
Conditions
neurological diseases
Beyond the preview
Go deeper on 2016-002805-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002805-21.